Egle Therapeutics is a biotechnology company focused on developing immunotherapies for oncology and autoimmune diseases.

Biotechnology

Health Care

Therapeutics

Egle Therapeutics

Egle Therapeutics' headquarters in Paris, France

John Celebi

The Research and Development team at Egle Therapeutics is dedicated to exploring and developing innovative immunotherapies for cancer and autoimmune diseases. Comprising research scientists, engineers, a bioinformatician, and a target discovery team leader, the team focuses on identifying novel therapeutic targets, conducting preclinical studies, and leveraging advanced bioinformatics tools to accelerate the development of cutting-edge treatment options.

Research and Development

This department conducts and oversees clinical studies to advance medical science and improve patient care.

Clinical Research

This department provides strategic oversight and governance to guide the organization's vision and direction.

Executive Leadership

This department manages communication and relationships with various media outlets.

Media Relations

This department provides strategic oversight and governance to guide the organization's direction.

Board of Directors

This department manages financial planning, budgeting, and operational functions within the organization.

Egle Therapeutics

Org chart

Teams

Research and Development

Clinical Research

Executive Leadership

Media Relations

Board of Directors

Finance and Operations

Offices

Egle Therapeutics

Org chart

Teams

Research and Development

Clinical Research

Executive Leadership

Media Relations

Board of Directors

Finance and Operations

Offices

Related companies